Clinical studies recruiting near Dijon

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Pre
Phase N/A · Dijon University Hospital · Nantes University Hospital · NCT05856565 A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · CHU Dijon Bourgogne - Service Hématologie Clinique · The Lymphoma Academic Research Organisation · NCT07018752 Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic An
Phase 2 · Chu Dijon Bourgogne · Centre Hospitalier Universitaire Dijon · NCT05089227 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU de Dijon · Fondation Hôpital Saint-Joseph · NCT05674994 DVT Burden and the Risk of Post-thrombotic Syndrome
NA · CHU de Dijon · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06385353 Impact of Motor Imagery in the Functional Rehabilitation of Patients With Chronic Low Back Pain: a Randomised Controlled
NA · CHU Dijon Bourgogne · Centre Hospitalier Universitaire Dijon · NCT07111286 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Centre Georges François Leclerc ( Site 1312) · Merck Sharp & Dohme LLC · NCT06393374 Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endo
Phase 3 · Chu Dijon · Gustave Roussy, Cancer Campus, Grand Paris · NCT06712472 A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · Centre Georges François Leclerc · Lumara Bio Oncologics GmbH · NCT05706129 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Centre Hospitalier Universitaire De Dijon · Alfasigma S.p.A. · NCT06865417 Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease
Phase N/A · Centre Hospitalier Universitaire de Dijon · Centre Hospitalier Intercommunal Creteil · NCT06987461 French Colorectal ESD Cohort in Experts Centers
Phase N/A · CHU de Dijon · University Hospital, Limoges · NCT04592003 A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome S
Phase N/A · CHU Dijon Bourgogne · Centre Hospitalier Universitaire Dijon · NCT06875089 Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · CHU Dijon · Hospices Civils de Lyon · NCT03593317 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Francois Mitterrand Hospital · Poitiers University Hospital · NCT05686850 Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · University Hospital Bocage · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Centre Hospitalier Universitaire de Dijon - Hopital Francois · Amgen · NCT07037433 Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
Phase 2 · Centre Georges-François Leclerc (CGFL) · Centre Hospitalier Universitaire de Besancon · NCT06425133 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · Crlcc Georges Francois Leclerc · NovoCure Ltd. · NCT06924099 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · René Olivier Casasnovas · Hospices Civils de Lyon · NCT05444712 Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete
NA · CLCC Georges François Leclerc · Institut Curie · NCT04731610 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · CHU de Dijon · The Lymphoma Academic Research Organisation · NCT06006117 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Centre Hospitalier Universitaire Dijon Bourgogne Medecine In · argenx · NCT06544499 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Centre Georges-Francois Leclerc · Turning Point Therapeutics, Inc. · NCT03093116 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
Phase 2 · Chu Dijon Bourgogne · The Lymphoma Academic Research Organisation · NCT06271057 EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
NA · Centre Georges-François Leclerc · Centre Georges Francois Leclerc · NCT04141462 Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Sho
Phase 3 · CHU Dijon Bourgogne · Centre Hospitalier Universitaire Dijon · NCT07063680 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Phase 3 · CHU Dijon-Hôpital François Mitterrand · Assistance Publique - Hôpitaux de Paris · NCT05387954

Look up another city

Look up another condition